Latest Headlines

Latest Headlines

How a massive kickback scheme eroded Olympus' corporate culture

In 2012, Olympus warned European hospitals that one of its medical scopes was harboring dangerous bacteria. More than two years later, U.S. hospitals reported infectious outbreaks linked to the same scope that ultimate infected more than 250 people between 2012 and 2015. The patient safety debacle left many wondering how this could happen. A massive kickback scheme that predated the outbreak offers some belated clues, revealing an eroded corporate culture that valued profits over compliance, regardless of the repercussions.

Olympus pays $646M to settle kickback allegations

The nation's largest distributor of endoscopes has agreed to pay $646 million to settle criminal and civil claims that the company offered various kickbacks to hospitals and doctors that signed deals to purchase medical equipment, according to the Department of Justice.  

FDA gives approval to Olympus duodenoscope's modified design

The Food and Drug Administration has cleared Olympus' modified design and labeling of its TJF-Q180V duodenoscope that was linked to a superbug outbreak. 

Hospital opacity on medical errors helped create the duodenoscope scandal

The dirty duodenoscope scandal is ugly and troubling, and there is a lot of blame to go around.

FDA sends warning letters to 3 manufacturers of superbug-linked scopes

The Food and Drug Administration has sent warning letters to three major manufacturers of a specialized medical scope linked to deadly "superbug" outbreaks at hospitals.

FDA advisory panel: Superbug-linked scopes put patients in danger

An advisory panel convened by the Food and Drug Administration urged the agency to better protect patients from specialized medical scopes linked to recent superbug outbreaks, the  L.A. Times  reports.